| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | 3.430 | 9.550 | 23.988 | 30.043 | 42.218 | 52.389 |
| Total Income - EUR | - | - | - | - | 3.430 | 9.550 | 24.085 | 30.986 | 43.234 | 52.389 |
| Total Expenses - EUR | - | - | - | - | 2.578 | 6.872 | 8.271 | 10.083 | 14.693 | 19.144 |
| Gross Profit/Loss - EUR | - | - | - | - | 853 | 2.677 | 15.814 | 20.903 | 28.541 | 33.245 |
| Net Profit/Loss - EUR | - | - | - | - | 750 | 2.395 | 15.104 | 20.020 | 28.133 | 31.690 |
| Employees | - | - | - | - | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Sacre Coeur Vascular S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | 0 | 0 | 0 | 3.290 | 2.209 | 712 |
| Current Assets | - | - | - | - | 820 | 7.211 | 16.844 | 28.211 | 28.987 | 38.100 |
| Inventories | - | - | - | - | 0 | 6.039 | 4.429 | 2.625 | 2.617 | 0 |
| Receivables | - | - | - | - | 196 | 711 | 10.740 | 19.836 | 15.293 | 21.361 |
| Cash | - | - | - | - | 624 | 461 | 1.675 | 5.751 | 11.077 | 16.739 |
| Shareholders Funds | - | - | - | - | 792 | 3.172 | 15.153 | 20.069 | 28.181 | 31.739 |
| Social Capital | - | - | - | - | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | - | - | - | - | 28 | 4.039 | 1.691 | 10.413 | 3.015 | 7.074 |
| Income in Advance | - | - | - | - | 0 | 0 | 0 | 1.019 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Sacre Coeur Vascular S.r.l.